[Frontiers in Bioscience 3, d961-972, September 1, 1998]
Reprints
PubMed
CAVEAT LECTOR




Table of Conents
 Previous Section   Next Section

PHYSIOLOGIC IMPORTANCE OF PROTEIN PHOSPHATASE INHIBITORS

Carey J. Oliver and Shirish Shenolikar

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710

Received 8/14/98 Accepted 8/20/98

TABLE OF CONTENTS

1.Abstract
2.Introduction
2.1. Introduction to protein serine/threonine phosphatases
2.1.1. Protein phosphatase 1
2.1.2. Protein phosphatase 2A
2.1.3. Protein phosphatase 2B
2.1.4. Other protein serine/threonine phosphatases
3.Protein phosphatase inhibitors
3.1. PP1 inhibitors
3.1.1. Inhibitor-1
3.1.1.1. I-1 and Glycogen Metabolism
3.1.1.2. I-1 and Synaptic Plasticity
3.1.1.3. I-1 and Cell Growth
3.1.1.4. I-1 and Muscle Contraction
3.1.2. DARPP-32
3.1.2.1. DARPP-32 and Na/K-ATPase
3.1.2.2. DARPP-32, Lipogenesis and Lipolysis
3.1.3. Inhibitor-2
3.1.3.1. I-2 and Sperm Motility
3.1.4. NIPP-1
3.1.4.1. NIPP-1 and RNA Metabolism
3.1.5. RIPP-1 3.1.6. CPI17
3.2. PP2A inhibitors
3.2.1. I1PP2A
3.2.2. I2PP2A
3.3. Endogenous PP2B inhibitors
4. Phosphatase inhibitors and human disease
5.Perspectives
6.References
7. Entire manuscript

Key words: Phosphatases, Inhibitors, Hormone Control, Glycogen Metabolism, Long-Term Potentiation

Search OMIM (Online Mendelian Inheritance in Man) to find related articles
This form requires a WWW Client such as Netscape, XMosaic, Lynx that supports fill-in forms.

Enter one or more search keywords:

To Search all fields, leave the following boxes unchecked. To narrow your search to certain specific fields, check the boxes next to those fields' names. SeeQuery Help for other ways to search. Title: OMIM Number: Allelic Variants: Text: References: Clinical Synopsis: Gene Map Disorder: Contributors: See only records which have been changed in the past Display at most